Advertisement
A novel online pulmonary rehabilitation program is non-inferior to conventional face-to-face pulmonary rehabilitation for patients with moderate chronic obstructive pulmonary disease (COPD)

ATS: Online Pulmonary Rehab Non-Inferior for COPD

0
Online supported PR was non-inferior to face-to-face model for chronic obstructive pulmonary disease
Older adults treated at major teaching facilities are less likely to die in the weeks and months following their discharge than patients admitted to community hospitals

Mortality Rates Found Lower at Major Teaching Hospitals

0
Researchers assessed 30-day survival for older patients
Patients with lung cancer have a strikingly higher-than-normal risk of suicide

ATS: Cancer-Related Suicide Risk Highest for Lung Cancer Patients

0
Odds up four-fold compared to people in the general population
Bronchial thermoplasty

ATS: Bronchial Thermoplasty Has Lasting Benefits for Asthma

0
Reduction in severe exacerbations, hospitalizations, ER visits in first and second year of follow-up
Most black people in the United States with sleep apnea or insomnia don't get their sleep disorder diagnosed

ATS: Sleep Apnea, Insomnia in Blacks Often Go Undiagnosed

0
High prevalence of undiagnosed sleep disorders seen in study population
Filtered cigarettes might be even more unhealthy than unfiltered ones

Filtered Cigarettes May Up Rates of Lung Adenocarcinoma

0
Design of cigarette filters with ventilation implicated in rising rates
For patients with acute respiratory distress syndrome

ATS: Lower ARDS Mortality at High-Volume Intensive Care Units

0
Lower ICU mortality, hospital length of stay for acute respiratory distress syndrome at high-volume ICUs
For patients with vasodilatory shock that does not respond to high-dose vasopressors

ATS: Angiotensin II Improves BP in Vasodilatory Shock

0
Angiotensin II effective for vasodilatory shock in patients not responding to conventional vasopressors
Benralizumab is associated with a significant reduction in glucocorticoid doses among adults with severe asthma

ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma

0
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline
The majority of medical practices have dismissed patients

Nine of Ten Practices Surveyed Have Dismissed Patients

0
Reasons include inappropriate behavior toward staff, violation of Rx policies, repeatedly missed appointments